Covidien has alerted customers for its technetium-99m generators about impending shortages caused by the unexpected shutdown of the Dutch nuclear reactor that serves as its main source of molybdenum-99.
Covidien has alerted customers for its technetium-99m generators about impending shortages caused by the unexpected shutdown of the Dutch nuclear reactor that serves as its main source of molybdenum-99.
General manager Rick Lytle announced the following changes Aug. 27 to the production schedule for its Ultra-Technekow DTE Tc-99m generator:
Covidien depends mainly on the High Flux reactor at Petten in the Netherlands for the production of MO-99 isotope, the precursor isotope to Tc-99m, which is produced as MO-99 decays. The isotope supply chain is susceptible to shortages because of the 66-hour half-life of MO-99.
The Netherlands Energy Research & Consultancy Group announced Aug. 26 that isotope production at the Petten research reactor would cease for at least one month while technicians track down the source of a gas leak between the reactor and the coolant system that was discovered during routine maintenance. Covidien also receives source material from reactors in Europe, Canada, and South Africa. In a written statement, however, the Hazelwood, MO, company said that alternative sources cannot make up for the entire shortfall. The firm is also increasing thallous chloride (TI-201) production as an alternative option for cardiac studies. The company did not disclose how many customers are affected, though they include nuclear medicine facilities in the U.S., Europe, Latin American, Canada, and parts of Asia. For more information from the Diagnostic Imaging archives:
Nuclear medicine braces for effects of Petten reactor shutdown
SNM panel finds no easy path to expand molybdenum-99 supplies
Canadian agency pulls plug on molybdenum reactors
Isotope supply crash drives push for new moly sources
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.